
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.300 | 0.300 | 0.000 |
Shares | 99.700 | 99.700 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.229 | 19.690 |
Price to Book | 2.934 | 3.813 |
Price to Sales | 2.635 | 2.219 |
Price to Cash Flow | 10.441 | 14.685 |
Dividend Yield | 3.022 | 1.485 |
5 Years Earnings Growth | 5.723 | 10.021 |
Number of long holdings: 26
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 8.30 | 105.22 | +1.15% | |
AstraZeneca | GB0009895292 | 7.76 | 12,650.0 | +1.57% | |
J&J | US4781601046 | 7.75 | 188.64 | +1.43% | |
Roche Holding Participation | CH0012032048 | 7.40 | 286.80 | +0.88% | |
Merck&Co | US58933Y1055 | 5.28 | 89.19 | -0.36% | |
Bayer | DE000BAY0017 | 4.60 | 28.85 | -0.93% | |
Gilead | US3755581036 | 3.98 | 112.69 | +1.93% | |
AbbVie | US00287Y1091 | 3.88 | 233.91 | -1.12% | |
GSK plc | GB00BN7SWP63 | 3.77 | 1,628.50 | -1.12% | |
Takeda Pharmaceutical | JP3463000004 | 3.64 | 4,258.0 | -0.91% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seligson & Co Global Top 25 Brands | 674.82M | -4.06 | 5.17 | 10.01 | ||
Seligson Co Global Top 25 Brands Fu | 674.82M | -4.07 | 5.16 | 10.05 | ||
FI4000283031 | 654.58M | -2.59 | 16.31 | - | ||
Seligson North American B | 582.58M | -1.23 | 14.62 | 14.00 | ||
Seligson & Co North American A | 582.58M | -1.13 | 14.72 | 14.10 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review